A new study shows the Pfizer-BioNTech vaccine remains 90% effective at preventing COVID-19 hospitalizations for up to six months after being fully vaccinated, even with the more transmissible delta ...
Separately, per the Pfizer-issued report, interim analyses of an ongoing second study in standard-risk adults (EPIC-SR) showed a 70% reduction in hospitalization and no deaths in the treated ...
BioNTech said May 10 there is “no evidence” supporting the need to adapt the COVID-19 vaccine it developed with Pfizer to be more effective against coronavirus variants. As international COVID-19 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback